Aczone (Dapsone Gel 5%)

Aczone is topical Dapsone Gel 5% and was originally created as an acne treatment. Recent efforts by the owners of Aczone, Allergan, have attempted to position Aczone as a rosacea treatment.

Recent Rosacea Blog Posts

A large Phase II Clinical Trial for treating rosacea with Aczone is looking for participants. The trial aims to compare Aczone (5% topical dapsone gel) with the vehicle and Metrogel 1%. The purpose of this study is to evaluate the safety and effectiveness of ACZONE gel compared to placebo (inactive substance), MetroGel and a combination […]

Continue Reading

The U.S. Food and Drug Administration (FDA) has approved Aczone (dapsone) Gel, 5% for the topical treatment of acne vulgaris in patients 12 years and older. Aczone is an aqueous topical gel containing 5% dapsone. Aczone has been shown to achieve statistically significant percent reduction in the number of acne lesions and better success rate […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.